4.5 Article

Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example

Journal

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 67, Issue 5, Pages 558-564

Publisher

WILEY
DOI: 10.1111/j.1365-2125.2009.03400.x

Keywords

adverse drug reactions; consumers; media exposure; patients; pharmacovigilance; statins

Ask authors/readers for more resources

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot More and more countries accept patient reporting in their spontaneous reporting systems. center dot Media exposure about drugs can influence patients and health professionals. center dot Evaluation of patient reporting of adverse drug reactions is needed to provide further evidence of its benefits. WHAT THIS STUDY ADDS center dot Patient reporting compared with reporting by health professionals after media attention about statins. center dot Patient reports provide additional insight into impact on daily life, the patient-health professional relationship and general worries next to health professionals' reports. To compare adverse drug reaction (ADR) reports from patients and health professionals after the broadcast of a Dutch television consumer programme about the benefits and risks of statins. We performed a quantitative and qualitative analysis on patients' and health professionals' reports of ADRs to statins. These reports were received by the Netherlands Pharmacovigilance Centre Lareb between March 2007 and August 2007. Quantitative data consisted of patient age and gender, number of received reports and characteristics of the report (most frequently reported ADRs, seriousness, drug discontinuation and outcome of the reported reaction). Open text fields in the ADR reporting form were categorized and a content analysis was carried out. Media attention led to a peak in patient reporting of ADRs but not in reporting by health professionals. There were no differences between patient and health professional reports in seriousness of the ADRs and drug cessation. Patients reported nonrecovery more often than health professionals. The TV programme is mentioned as a reason for drug discontinuation in almost 30 reports. Patients often felt that they did not receive sufficient information and that their concerns were not adequately addressed by healthcare professionals. Media attention affects drug use and ADR reporting by patients. Patient reports can provide additional information, making them a useful source of information next to health professional reports. Content analysis provides vital insights into the impact of statins on daily life, and patients' concerns about adverse reactions should be recognized in reports to national pharmacovigilance centres.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Pharmacology & Pharmacy

Fifteen years of patient reporting -what have we learned and where are we heading to?

Florence van Hunsel, Linda Harmark, Lean Rolfes

EXPERT OPINION ON DRUG SAFETY (2019)

Article Pharmacology & Pharmacy

Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase

Florence van Hunsel, Sonja van de Koppel, Souad Skalli, Andrea Kuemmerle, Lida Teng, Jia-bo Wang, Joanne Barnes

FRONTIERS IN PHARMACOLOGY (2019)

Article Pediatrics

Psychiatric adverse drug reactions in the paediatric population

Corine Ekhart, Tjalling de Vries, Florence van Hunsel

ARCHIVES OF DISEASE IN CHILDHOOD (2020)

Article Medicine, Research & Experimental

Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands

Pieter J. Glerum, Marc Maliepaard, Vincent de Valk, Joep H. G. Scholl, Florence P. A. M. van Hunsel, Eugene P. van Puijenbroek, David M. Burger, Kees Neef

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Letter Public, Environmental & Occupational Health

Insight into the Severity of Adverse Drug Reactions as Experienced by Patients

Lean Rolfes, Michelle Haaksman, Florence van Hunsel, Eugene van Puijenbroek

DRUG SAFETY (2020)

Article Pharmacology & Pharmacy

Opportunities for changes in the drug product design to enhance medication safety in older people: Evaluation of a national public portal for medication incidents

Fatma Karapinar-Carkit, Patricia M. L. A. van den Bemt, Mariam Sadik, Brigit van Soest, Wilma Knol, Florence van Hunsel, Diana A. van Riet-Nales

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Article Public, Environmental & Occupational Health

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Linda Harmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Noren, Florence van Hunsel

DRUG SAFETY (2020)

Correction Public, Environmental & Occupational Health

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands (vol 53, pg 861, 2020)

Linda Harmark, Gerda Weits, Rietje Meijer, Federica Santoro, G. Niklas Noren, Florence van Hunsel

DRUG SAFETY (2020)

Article Public, Environmental & Occupational Health

Patient Organizations' Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation

Katherine Chinchilla, Cristiano Matos, Victoria Hall, Florence van Hunsel

Summary: This study aims to understand patient organizations' perceptions of pharmacovigilance, the barriers they face when implementing pharmacovigilance activities, and their interaction with other stakeholders. The results suggest that creating awareness campaigns, conducting more research, providing education, and improving communication are key strategies to stimulate patient organization participation and promote drug safety. Patient organizations are increasingly recognized as important stakeholders in pharmacovigilance, but still encounter internal and external barriers that hinder their full involvement.

DRUG SAFETY (2021)

Article Obstetrics & Gynecology

Mental health status of pregnant and breastfeeding women during the COVID-19 pandemic-A multinational cross-sectional study

Michael Ceulemans, Veerle Foulon, Elin Ngo, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan L. Richardson, Titia Hompes, Hedvig Nordeng

Summary: This multinational study found high levels of depressive symptoms and generalized anxiety among pregnant and breastfeeding women during the COVID-19 outbreak. Risk factors associated with poor mental health included having a chronic mental illness, a chronic somatic illness in the postpartum period, smoking, having an unplanned pregnancy, professional status, and living in the UK or Ireland.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)

Article Environmental Sciences

Vaccine Willingness and Impact of the COVID-19 Pandemic on Women's Perinatal Experiences and Practices-A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic

Michael Ceulemans, Veerle Foulon, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan Luke Richardson, Karel Allegaert, Hedvig Nordeng

Summary: During the COVID-19 pandemic, pregnant and breastfeeding women showed hesitancy towards COVID-19 vaccines, with views influenced by education level and employment status. The pandemic had a negative impact on pregnancy experiences, access to healthcare, and breastfeeding support for many women.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Environmental Sciences

Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries

Michael Ceulemans, Veerle Foulon, Alice Panchaud, Ursula Winterfeld, Leo Pomar, Valentine Lambelet, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan Luke Richardson, Hedvig Nordeng

Summary: Insight into the epidemiology of perinatal medication use during the COVID-19 pandemic is scarce. A cross-sectional study conducted in five countries investigated the prevalence and type of medications used by pregnant and breastfeeding women during the first wave of the pandemic. The study found that perinatal medication use was highly prevalent, with the most commonly used medications belonging to the nervous system, respiratory system, alimentary tract/metabolism, and musculo-skeletal system categories. Factors such as chronic illness, country, maternal age, SARS-CoV-2 testing, professional status, and time since delivery were associated with medication use.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Environmental Sciences

Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study

Eva Gerbier, Guillaume Favre, Fatima Tauqeer, Ursula Winterfeld, Milos Stojanov, Alison Oliver, Anneke Passier, Hedvig Nordeng, Leo Pomar, David Baud, Alice Panchaud, Carla Meyer-Massetti, Michael Ceulemans

Summary: Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. This study investigated the prevalence and patterns of medication use among this population during the third wave of the pandemic. The results showed that the medication use patterns were mostly similar to those of the first wave and the pre-pandemic period, with lower prevalence of anti-infectives.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Pharmacology & Pharmacy

Diabetes patient's pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation

Cristiano Matos, Florence van Hunsel, Rogerio Tavares Ribeiro, Nascimento O. Do Dulce, Joao Filipe Raposo

THERAPEUTIC ADVANCES IN DRUG SAFETY (2020)

Article Chemistry, Medicinal

Inter-individual differences in pharmacokinetics of vitamin B6: A possible explanation of different sensitivity to its neuropathic effects

Misha F. Vrolijk, Geja J. Hageman, Sonja van de Koppel, Florence van Hunsel, Aalt Bast

PHARMANUTRITION (2020)

No Data Available